- call +1-201-465-4211
- email sales@mrinsights.biz
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
Scope of the Report:
This report focuses on the Intranasal Drug Delivery in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Intranasal Drug Delivery Devices includes Multidose and Uni/bidose, and the proportion of Multidose in 2017 is about 85%, and the proportion is in decreasing trend from 2013 to 2017.
North America, especially The United States, will still play an important role which cannot be ignored, with market size of 340 million USD in 2017 and will be 770 million USD in 2025. Any changes from United States might affect the development trend of Intranasal Drug Delivery Devices. North America region is the largest consumer of Intranasal Drug Delivery Devices, with a market share nearly 43% in 2017.
Europe also plays important roles in global market, with market size of 270 million USD in 2017, enjoying sales market share nearly 34% in 2017.The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
The worldwide market for Intranasal Drug Delivery is expected to grow at a CAGR of roughly 10.4% over the next five years, will reach 1410 million US$ in 2023, from 780 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
BD
AptarGroup
3M
Teleflex
H＆T Presspart
Bespak
Pfizer
Novartis
Becton Dickinson
Johnson & Johnson
Merck
GlaxoSmithKline
Nemera
OptiNose
AstraZeneca
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Multidose
Uni/bidose
Market Segment by Applications, can be divided into
Personal Use
Hospital Use
There are 15 Chapters to deeply display the global Intranasal Drug Delivery market.
Chapter 1, to describe Intranasal Drug Delivery Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Intranasal Drug Delivery, with sales, revenue, and price of Intranasal Drug Delivery, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Intranasal Drug Delivery, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Intranasal Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Intranasal Drug Delivery sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Intranasal Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Multidose
1.2.2 Uni/bidose
1.3 Market Analysis by Applications
1.3.1 Personal Use
1.3.2 Hospital Use
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BD
2.1.1 Business Overview
2.1.2 Intranasal Drug Delivery Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BD Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AptarGroup
2.2.1 Business Overview
2.2.2 Intranasal Drug Delivery Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AptarGroup Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 3M
2.3.1 Business Overview
2.3.2 Intranasal Drug Delivery Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 3M Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teleflex
2.4.1 Business Overview
2.4.2 Intranasal Drug Delivery Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teleflex Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 H＆T Presspart
2.5.1 Business Overview
2.5.2 Intranasal Drug Delivery Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 H＆T Presspart Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bespak
2.6.1 Business Overview
2.6.2 Intranasal Drug Delivery Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bespak Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Intranasal Drug Delivery Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Intranasal Drug Delivery Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Becton Dickinson
2.9.1 Business Overview
2.9.2 Intranasal Drug Delivery Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Becton Dickinson Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Intranasal Drug Delivery Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Merck
2.11.1 Business Overview
2.11.2 Intranasal Drug Delivery Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Merck Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 GlaxoSmithKline
2.12.1 Business Overview
2.12.2 Intranasal Drug Delivery Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 GlaxoSmithKline Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Nemera
2.13.1 Business Overview
2.13.2 Intranasal Drug Delivery Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Nemera Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 OptiNose
2.14.1 Business Overview
2.14.2 Intranasal Drug Delivery Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 OptiNose Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 AstraZeneca
2.15.1 Business Overview
2.15.2 Intranasal Drug Delivery Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 AstraZeneca Intranasal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intranasal Drug Delivery Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Intranasal Drug Delivery Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intranasal Drug Delivery Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Intranasal Drug Delivery Manufacturer Market Share in 2017
3.3.2 Top 6 Intranasal Drug Delivery Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Intranasal Drug Delivery Market Analysis by Regions
4.1 Global Intranasal Drug Delivery Sales, Revenue and Market Share by Regions
4.1.1 Global Intranasal Drug Delivery Sales and Market Share by Regions (2013-2018)
4.1.2 Global Intranasal Drug Delivery Revenue and Market Share by Regions (2013-2018)
4.2 North America Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
4.3 Europe Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
4.5 South America Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
5 North America Intranasal Drug Delivery by Countries
5.1 North America Intranasal Drug Delivery Sales, Revenue and Market Share by Countries
5.1.1 North America Intranasal Drug Delivery Sales and Market Share by Countries (2013-2018)
5.1.2 North America Intranasal Drug Delivery Revenue and Market Share by Countries (2013-2018)
5.2 United States Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
5.3 Canada Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
5.4 Mexico Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
6 Europe Intranasal Drug Delivery by Countries
6.1 Europe Intranasal Drug Delivery Sales, Revenue and Market Share by Countries
6.1.1 Europe Intranasal Drug Delivery Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Intranasal Drug Delivery Revenue and Market Share by Countries (2013-2018)
6.2 Germany Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
6.3 UK Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
6.4 France Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
6.5 Russia Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
6.6 Italy Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
7 Asia-Pacific Intranasal Drug Delivery by Countries
7.1 Asia-Pacific Intranasal Drug Delivery Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intranasal Drug Delivery Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Intranasal Drug Delivery Revenue and Market Share by Countries (2013-2018)
7.2 China Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
7.3 Japan Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
7.4 Korea Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
7.5 India Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
8 South America Intranasal Drug Delivery by Countries
8.1 South America Intranasal Drug Delivery Sales, Revenue and Market Share by Countries
8.1.1 South America Intranasal Drug Delivery Sales and Market Share by Countries (2013-2018)
8.1.2 South America Intranasal Drug Delivery Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
8.3 Argentina Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
8.4 Colombia Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
9 Middle East and Africa Intranasal Drug Delivery by Countries
9.1 Middle East and Africa Intranasal Drug Delivery Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intranasal Drug Delivery Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Intranasal Drug Delivery Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
9.3 UAE Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
9.4 Egypt Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
9.5 Nigeria Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
9.6 South Africa Intranasal Drug Delivery Sales and Growth Rate (2013-2018)
10 Global Intranasal Drug Delivery Market Segment by Type
10.1 Global Intranasal Drug Delivery Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intranasal Drug Delivery Sales and Market Share by Type (2013-2018)
10.1.2 Global Intranasal Drug Delivery Revenue and Market Share by Type (2013-2018)
10.2 Multidose Sales Growth and Price
10.2.1 Global Multidose Sales Growth (2013-2018)
10.2.2 Global Multidose Price (2013-2018)
10.3 Uni/bidose Sales Growth and Price
10.3.1 Global Uni/bidose Sales Growth (2013-2018)
10.3.2 Global Uni/bidose Price (2013-2018)
11 Global Intranasal Drug Delivery Market Segment by Application
11.1 Global Intranasal Drug Delivery Sales Market Share by Application (2013-2018)
11.2 Personal Use Sales Growth (2013-2018)
11.3 Hospital Use Sales Growth (2013-2018)
12 Intranasal Drug Delivery Market Forecast (2018-2023)
12.1 Global Intranasal Drug Delivery Sales, Revenue and Growth Rate (2018-2023)
12.2 Intranasal Drug Delivery Market Forecast by Regions (2018-2023)
12.2.1 North America Intranasal Drug Delivery Market Forecast (2018-2023)
12.2.2 Europe Intranasal Drug Delivery Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intranasal Drug Delivery Market Forecast (2018-2023)
12.2.4 South America Intranasal Drug Delivery Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intranasal Drug Delivery Market Forecast (2018-2023)
12.3 Intranasal Drug Delivery Market Forecast by Type (2018-2023)
12.3.1 Global Intranasal Drug Delivery Sales Forecast by Type (2018-2023)
12.3.2 Global Intranasal Drug Delivery Market Share Forecast by Type (2018-2023)
12.4 Intranasal Drug Delivery Market Forecast by Application (2018-2023)
12.4.1 Global Intranasal Drug Delivery Sales Forecast by Application (2018-2023)
12.4.2 Global Intranasal Drug Delivery Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Intranasal Drug Delivery Picture
Table Product Specifications of Intranasal Drug Delivery
Figure Global Sales Market Share of Intranasal Drug Delivery by Types in 20
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
